Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

Description

This study is being done to investigate the colonization rate(growth rate) of a particular type of low-virulence (does not typically cause infection) bacterium called Propionibacterium, more specifically P acnes, the same bacterium that is responsible for the majority of acne. Information affecting hip surgery is currently unknown.

Conditions

Degenerative Osteoarthritis

Talk to us

Study Overview

On this page

Study Details

Study overview

This study is being done to investigate the colonization rate(growth rate) of a particular type of low-virulence (does not typically cause infection) bacterium called Propionibacterium, more specifically P acnes, the same bacterium that is responsible for the majority of acne. Information affecting hip surgery is currently unknown.

Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

Condition
Degenerative Osteoarthritis
Intervention / Treatment

-

Contacts and Locations

Denver

Colorado Joint Replacement, Denver, Colorado, United States, 80210

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients who are 18 to 79 85 years of age
  • * CJR primary joint arthroplasty patients who are receiving care at Porter Adventist Hospital
  • * CJR established primary knee or hip arthroplasty patients with a native hip joint (no replacement on the biopsy side) who volunteers as a research participant.
  • * CJR patients without a previous arthroplasty procedure who have established care with our practice.
  • * Previous history of hip infection
  • * Current antibiotic use or antibiotic use within the past week
  • * Previous history of Cutibacterium joint infection
  • * Current immunodeficiency disease or disorder
  • * Patients with active psoriatic disease or other focal inflammation over the hip
  • * Previous total hip arthroplasty (bilateral for the case of TKA patients and healthy volunteers, contralateral for THA patients)

Ages Eligible for Study

18 Years to 85 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Colorado Joint Replacement,

Jason M Jennings, MD DPT, PRINCIPAL_INVESTIGATOR, Colorado Joint Replacement

Study Record Dates

2024-12-31